, Volume 59, Issue 9–10, pp 551–554 | Cite as

Determination of Carvedilol in Human Plasma by High-Performance Liquid Chromatography Applying On-Line Deproteination and Column Switching

  • G. LamprechtEmail author
  • K. Stoschitzky


An HPLC-column switching method has been developed and validated for the determination of carvedilol in human plasma. 20 μL plasma was injected onto a Brownlee C8 column and the high molecular weight proteins were eluted isocratically. Carvedilol was separated from the majority of the components by a linear acetonitrile gradient. The fraction containing carvedilol was switched on-line onto a LiChrospher RP 18 column and separated isocratically from accompanying compounds applying 0.1 M triethylamine-methanol-acetonitrile = 17: 18:19 (v/v/v). The influence of pH and temperature on retention was investigated on both columns. No interference from other plasma components was observed. Reproducibility of the complete method was better than 4% and the limit of quantitation was 0.8 ng mL−1.


Column liquid chromatography Column switching On-line deproteination Carvedilol 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ruffolo RR Jr, Feuerstein GZ (1997) Cardiovasc Drugs Ther 11:247–256CrossRefPubMedGoogle Scholar
  2. Hirohashi M, Takasuna K, Tamura K, Yamaguchi K, Maekawa K, Yamada S, Iwasaki S, Yoshida M, Nomura M, Taguchi K (1990) Arzneim Forsch 40: 735–46Google Scholar
  3. Hokama N, Hobara N, Kameya H, Ohshiro S, Sakanashi M (1999) J Chromatogr B 732:233–238PubMedGoogle Scholar
  4. Behn F, Laer S, Scholz H (2001) J Chromatogr Sci 39:121–124PubMedGoogle Scholar
  5. Behn F, Laer S, Mir TS, Scholz H (2001) Chromatographia 53:641–644Google Scholar
  6. Reiff K (1987) J. Chromatogr. 413:355–62Google Scholar
  7. Varin F, Cubeddu LX, Powell JR (1986) J Pharmaceutical Sci 75:1195–1197Google Scholar
  8. Behn F, Laer S, Mir TS, Scholz H (2001) Chromatographia 53:641–64Google Scholar
  9. Gergov M, Robson JN, Duchoslav E, Ojanpera I (2000) J Mass Spectr 35:912–918CrossRefGoogle Scholar
  10. Behn F, Michels S, Laer S, Blaschke G (2001) J Chromatogr B 755:111–117CrossRefGoogle Scholar
  11. Clohs L, McErlane KM (2001) J Pharma Biomed Anal 24: 545–554CrossRefGoogle Scholar
  12. Lamprecht G, Gruber L, Stoschitzky K, Lindner W (2002) Chromatographia 56:25–29Google Scholar
  13. Boos K-S, Rudolphi A (1997) LC-GC 15:602–611Google Scholar
  14. Boos K-S, Rudolphi A (1997) LC-GC 15:814–823.Google Scholar
  15. Schafer C, Lubda D, Boos K-S, Unger K K (2001) Bioforum Int 5:120–123Google Scholar
  16. Lamprecht G, Kraushofer T, Stoschitzky K, Lindner W (2000) J Chromatogr B 740:219–226CrossRefGoogle Scholar
  17. Huber JFK, Lamprecht G (1995) J Chromatogr B 666:223–232CrossRefGoogle Scholar
  18. Stoschitzky K, Koshucharova G, Klein W, Müller F, Bühring K, Lamprecht G, Lindner W Cardiovasc. Drugs Ther submittedGoogle Scholar

Copyright information

© Friedr. Vieweg&Sohn Verlagsgesellschaft mbH 2004

Authors and Affiliations

  1. 1.Institute of Analytical ChemistryUniversity of ViennaViennaAustria
  2. 2.Karl Franzens UniversityDepartment of MedicineGrazAustria

Personalised recommendations